Incidence of Emergence Delirium in the PACU

Status Completed

Clinical Trial Summary

Emergence delirium (ED) is serious complication in the postoperative period in paediatric anaesthesia, reported incidence is 20-60%. It is characterized by psychomotor and perception disorder with excitation of paediatric patients. Emergence delirium has impact on morbidity and even on mortality of paediatric patients in the postoperative period. The potential risk factors for ED development include sevoflurane, which is the dominant anaesthetic agent used in the paediatric patients, and which is actually the only inhalation agent used for inhalation anaesthesia induction. The incidence of ED is higher in postoperative period, for example in the Post-anaesthesia Care Unit - PACU. Patients with ED are at higher risk of psychomotor anxiety, agitation, unintentional extraction of intravenous cannula, and nausea and vomiting. For the therapy of ED propofol, midazolam and eventually ketamine in a reduced dosage are used.

Clinical Trial Description

After the approval of the study by the Ethics Committee of the University hospital Brno and registration of the protocol at clinicaltrials.gov, the incidence of emergence delirium (ED) using PAED, WATCHA and Richmond agitation and sedation scale (RASS) score in patients hospitalized in the post-anaesthesia care unit (PACU) after general anaesthesia, in the Departement of paediatric anaesthesia and intensive care unit, University Hospital Brno in the term from 1.9.2020 until 30.6.2021 will be measured. Paediatric Emergence Delirium (PAED) score, WATCHA score and Richmond agitation and sedation scale (RASS) will be measured in 0., 5., 10., 15., and 20. minute after PACU admission and after obtaining RASS ≥ - 2 . Emergence delirium is defined as PAED score above 10 points. In the case of ED development, the duration of ED will be measured as well as the number of therapeutic interventions and the cumulative dose of administered sedatives. The average PAED, WATCHA, RASS scale will be reported, the incidence of postoperative nausea and vomiting (PONV) and the cumulative dose of administered antiemetics, the type of anaesthesia induction (inhalation vs. intravenous), type of anaesthesia (TIVA, combined, inhalational), length of the surgery, type of the surgery will be reported. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04531020
Study type	Observational
Source	Brno University Hospital
Contact
Status	Completed
Phase
Start date	October 1, 2020
Completion date	January 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03787849` - Epigenetics in PostOperative Pediatric Emergence Delirium	N/A
Completed	`NCT03788564` - The Association of Cardiac Ion Channel Related Gene Polymorphism and Prolonged QTc Interval After Endotracheal Intubation
Recruiting	`NCT01221025` - Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain	Phase 4
Not yet recruiting	`NCT06035757` - The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery	Phase 4
Not yet recruiting	`NCT04291820` - Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence	N/A
Completed	`NCT05124067` - Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children	Phase 1
Recruiting	`NCT05091242` - The PREVENT AGITATION Trial II - Children ≤1 Year	Phase 2/Phase 3
Completed	`NCT03330236` - EEG - Guided Anesthetic Care and Postoperative Delirium	N/A
Completed	`NCT05105178` - Verbal Stimulation of Orientation on Emergence Agitation	N/A
Completed	`NCT03285243` - Effect of Monochromatic Light on Incidence of Emergence Delirium in Children	N/A
Recruiting	`NCT04621305` - Remimazolam Reduces Emergence Delirium in Preschool Children Undergoing Laparoscopic Surgery by Sevoflurane Anesthesia	Phase 4
Completed	`NCT01096797` - Correlation Between Pain and Emergence Delirium After Adenotonsillectomy in Preschool Children	Phase 4
Recruiting	`NCT03330613` - Emergence Delirium and Recovery Time in Children	N/A
Recruiting	`NCT05872087` - Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries	Phase 1
Not yet recruiting	`NCT06387953` - Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy	N/A
Not yet recruiting	`NCT05883280` - The Effect of Binaural Sound on the Occurrence of Emergence Delirium in Children Undergoing Strabismus Surgery	N/A
Not yet recruiting	`NCT05821972` - Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate	Phase 4
Completed	`NCT03131375` - Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia	Phase 2/Phase 3
Active, not recruiting	`NCT04058899` - Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics	Phase 1/Phase 2
Completed	`NCT04292457` - Namsos Anaesthesia Children Outcome Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Incidence of Emergence Delirium in the PACU — PACUDEL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms